as on September 13, 2025 at 1:29 am IST
Day's Low
Day's High
0.85%
Downside
7.69%
Upside
52 Week's Low
52 Week's High
27.26%
Downside
132.48%
Upside
Check Pacific Biosciences Of California, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$351.4M
EPS (TTM)
-0.563
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-0.93
Industry PE ratio
-3.8535542168674697
P/B Ratio
0PEG Ratio
-0.17
EBITDA
-225.7M
Revenue (TTM)
156.1M
Profit Margin
0.00%
Return On Equity TTM
3968000.00%
Track how Pacific Biosciences Of California, Inc. P/E has moved over time to understand its valuation trends.
Pacific Biosciences Of California, Inc. in the last 5 years
Lowest (0.00x)
September 15, 2025
Industry (-3.85x)
September 15, 2025
Today (-0.93x)
September 15, 2025
Highest (0.00x)
September 15, 2025
Today’s Price to Earnings Ratio: -0.93x
Compare market cap, revenue, PE, and other key metrics of Pacific Biosciences Of California, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $351.4M | -84.02% | -0.93 | 0.00% | |
BUY | $152.2B | 150.39% | 61.14 | 13.55% | |
BUY | $146.6B | 82.11% | 50.77 | 12.25% | |
BUY | $232.8B | 25.47% | 16.78 | 32.43% | |
BUY | $120.6B | -12.59% | 25.98 | 13.63% |
The Pacific Biosciences Of California, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Pacific Biosciences Of California, Inc. investment value today
Current value as on today
₹69,780
Returns
Returns from Pacific Biosciences Of California, Inc. Stock
Dollar Returns*
₹5,139 (+5.14%)
Based on 20 analysts
55.00%
Buy
45.00%
Hold
0.00%
Sell
Based on 20 analysts, 55% of analysts recommend a 'BUY' rating for Pacific Biosciences Of California, Inc.. Average target price of $2.11
Get share price movements and forecasts by analysts on Pacific Biosciences Of California, Inc..
What analysts predicted
44.55%UPSIDE
Target Price
$2.11
Current Price
$1.17
Analyzed by
20 Analysts
Target
$2.11
Pacific Biosciences Of California, Inc. target price $2.11, a slight upside of 44.55% compared to current price of $1.17. According to 20 analysts rating.
Investment in Pacific Biosciences Of California, Inc. Shares on INDmoney has dropped by -73.63% over the past 30 days, indicating reduced transactional activity.
Time period: to
Search interest for Pacific Biosciences Of California, Inc. Stock has decreased by -38% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
Revenue is up for the last 2 quarters, 37.15M → 39.76M (in $), with an average increase of 6.6% per quarter
Profit Spike
Netprofit is up for the last 2 quarters, -426.07M → -41.93M (in $), with an average increase of 916.2% per quarter
Against Peers
In the last 1 year, Boston Scientific Corp. has given 23.3% return, outperforming this stock by 58.7%
Against Peers
In the last 3 years, Boston Scientific Corp. has given 143.4% return, outperforming this stock by 225.7%
Price Dip
In the last 7 days, PACB stock has moved down by -6.4%
Organisation | Pacific Biosciences Of California, Inc. |
Headquarters | 1305 O?Brien Drive, Menlo Park, CA, United States, 94025 |
Industry | Health Technology |
CEO | Mr. Christian O. Henry M.B.A. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Ms. Michele Farmer CPA | VP & Chief Accounting Officer |
Dr. Brett Atkins J.D., Ph.D. | General Counsel & Corporate Secretary |
Mr. David Ruggiero | Global Head of Sales & Service |
Ms. Natalie Welch | Chief People Officer |
Mr. Christian O. Henry M.B.A. | President, CEO & Director |
Mr. Mark Van Oene Ph.D. | Chief Operating Officer |
Dr. Stephen Turner Ph.D. | Co-Founder |
Mr. James R. Gibson II | Chief Financial Officer |
Pacific Biosciences Of California, Inc. share price today is $1.17 as on at the close of the market. Pacific Biosciences Of California, Inc. share today touched a day high of $1.26 and a low of $1.16.
Pacific Biosciences Of California, Inc. share touched a 52 week high of $2.72 on and a 52 week low of $0.85 on . Pacific Biosciences Of California, Inc. stock price today i.e. is closed at $1.17,which is 56.99% down from its 52 week high and 37.47% up from its 52 week low.
Pacific Biosciences Of California, Inc. market capitalisation is $0.00T as on .
Indian investors can start investing in Pacific Biosciences Of California, Inc. (PACB) shares with as little as ₹88.27 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Pacific Biosciences Of California, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Pacific Biosciences Of California, Inc. share’s latest price of $1.17 as on September 13, 2025 at 1:29 am IST, you will get 8.5470 shares of Pacific Biosciences Of California, Inc.. Learn more about
fractional shares .
Pacific Biosciences Of California, Inc. stock has given -84.02% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?